Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States.
نویسندگان
چکیده
Acute myocardial infarction (AMI) and stroke are unanticipated major healthcare events that require emergent and expensive care. Given the potential financial implications of AMI and stroke among uninsured patients, we sought to evaluate rates of catastrophic healthcare expenditures (CHEs), defined as expenses beyond financial means, in a period before the implementation of insurance expansion and protections in the Affordable Care Act.1 In a large, nationally representative database of inpatient hospitalizations, the National Inpatient Sample, we identified all AMI (Clinical Classification Software code 100 as the primary diagnosis) and stroke (International Classification of Diseases, Ninth Revision codes 430, 431, 432.x, 433.x1, 434.x1, or 436 as the primary diagnosis) hospitalizations among uninsured nonelderly adults (age,18–64 years) between 2008 and 2012. To estimate patient expenses relative to income, we obtained 2 data components from the National Inpatient Sample: hospitalization charges and an ordinal variable (value of 1–4) representing quartiles of median income based on residential ZIP code. However, patient incomes can vary widely for each income quartile, and assessing CHEs requires an estimate of patient-level income. Therefore, using a previously suggested microsimulation model for assessing patient-level income from community income quartiles,2,3 we estimated income for each patient from a 2-parameter gamma probability distribution. We used the US Gini coefficient (a measure of income inequality) of 0.411 to define the shape parameter and the community-level income corresponding to each quartile to define the scale parameter for the income curve for each quartile (Figure, A).4 As previously suggested, to prevent overestimation of CHE as a result of an underestimation of income, mean quartile income values were centered at the highest value of the quartile range for quartiles 1 to 3 and at 80% of the upper bound for quartile 4.3 Annual food expenditures were derived from US Bureau of Labor Statistics estimates of food-related expenses as a function of income.5 Postsubsistence income was the difference between income and food-related subsistence expenses. On the basis of previous literature,3 a hospitalization charge was classified as a CHE if charges exceeded 40% of the postsubsistence income. Bootstrapped means and 95% confidence intervals were obtained by repeating the model over 10 000 simulations. All estimates were indexed to the year 2012 on the basis of the Consumer Price Index. National estimates were obtained with survey-analysis tools in SAS 9.4 (SAS Institute Inc, Cary, NC). We identified 39 296 AMI (81% patients ≥45 years of age, 26% women, 13% blacks, 38% in lowest income quartile, and 12% in highest quartile) and 29 182 stroke (82% patients ≥45 years of age, 39% women, 26% blacks, 41% in lowest income quartile, and 11% in highest quartile) hospitalizations among uninsured nonelderly, corresponding to 188 192 and 139 687 nationally. The uninsured represented 15% of both AMI and stroke hospitalizations among nonelderly. Median hospitalization charges Rohan Khera, MD* Jonathan C. Hong, MD, MHS* Anshul Saxena, PhD Alejandro Arrieta, PhD Salim S. Virani, MD, PhD Ron Blankstein, MD James A. de Lemos, MD Harlan M. Krumholz, MD, SM Khurram Nasir, MD, MPH
منابع مشابه
Tenecteplase versus reteplase in acute myocardial infarction: A network meta-analysis of randomized clinical trials
Background: Acute myocardial infarction (AMI) is the leading cause of death throughout the world. One of the standard approaches to treatment of AMI is fibrinolysis. The study was conducted to evaluate the clinical efficacy of tenecteplase versus reteplase through network meta-analysis for AMI. Methods: Randomized trials were comprehensively searched in PubMed, Scopus, Cochrane library, a...
متن کاملTenecteplase versus reteplase in acute myocardial infarction: A network meta-analysis of randomized clinical trials
Background: Acute myocardial infarction (AMI) is the leading cause of death throughout the world. One of the standard approaches to treatment of AMI is fibrinolysis. The study was conducted to evaluate the clinical efficacy of tenecteplase versus reteplase through network meta-analysis for AMI. Methods: Randomized trials were comprehensively searched in PubMed, Scopus, Cochrane library, a...
متن کاملبرآورد میزان پرداخت از جیب و هزینه های کمرشکن بیماران قلبی- عروقی در استان خوزستان
Background and Aim: The World Health Organization (WHO) has placed special emphasis on the protection of families against the costs of health services. Patients suffer not only from the burden of a disease, but also from the burden of their health costs. The aim of this study was to estimate out-of-pocket costs and to identify the factors that affect catastrophic expenditures among patients wit...
متن کاملThe streptokinase therapy complications and its associated risk factors in patients with acute ST elevation myocardial infarction
Acute myocardial infarction (AMI) is one of the main leading causes of mortality and morbidity. Despite the progress in the treatment of AMI, streptokinase is still being used in many countries. Because of the critical condition of patients with AMI and complications of streptokinase therapy, this study was performed to evaluate the pattern of adverse drug reaction (ADRs) induced by streptokina...
متن کاملPayer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2.
BACKGROUND Prior studies have suggested that payer status may be an important determinant of medical resource utilization and outcome in acute myocardial infarction (AMI). METHODS A national cohort of 332,221 patients with AMI enrolled from June 1994 to July 1996 were compared within 5 payer groups to ascertain the influence of payer status on hospital resource allocation for AMI in the Unite...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Circulation
دوره 137 4 شماره
صفحات -
تاریخ انتشار 2018